have affected studies on seasonality correlation between asthma and rhinovirus infection. The references provided in this article on the subject (5, 8, 9) are up-to-date. -Conclusion should be rephrased from `influenza hospitalizations are significantly correlated with asthma hospitalizations at the population-level` to `influenza hospitalizations are significantly correlated with asthma hospitalizations at the population-level among adults (>18 years old)`.
REVIEWER
Howraman Meteran Respiratory Research Unit Bispebjerg University Hospital Copenhagen, Denmark REVIEW RETURNED 17-Dec-2017
GENERAL COMMENTS
Dear authors, thanks for submitting your manuscript with an interesting and relevant topic.
Before acceptance for publication can be considered I have some points that I believe need to be solved:
Introduction: 1. In the introduction section, line 8 it says that the national prevalence of asthma has increased by 25.7 million. It would be more relevant to give the change in % rather than absolute numbers.
Methods: 2a: The authors use a long list of statistical approaches to analyse data. I am sure that it is readable and understable for the reader working in this field. However, it would be a great help for the average if the various models and concepts are explained, optionally as as supplemental material which is referred to in the main document. 2b: The authors have used SPARCS to extract data. Although SPARCS is briefly explained it is necessary with a reference. 3. Page 7, line 16: AIC needs a brief explanation and/or a reference. 4. The authors calculate the percent excess risk to identify a peak month. Was is the rationale for using 1 months and not e.g. 2 months or 8 weeks?
Results: 5. The authors explain the peak in influenza cases in 2009 with a good explanation (Figure 1 ). The same plot reveals two other peaks in asthma exacerbations in 2004 and 2005, but the authors do not mention these? Why are these not interesting? Discussion 6. The authors define age groups and find that the correlation between influenza and astma was only significant amongst age groups 18 and older. Do the authors have any reason to believe that the correlation is present/absent with 18 years of age as a cut-off? A sensitivity analysis would be preferable.
7. Page 11, line 58, needs some references.
8. The authors (very relevantly) discuss the impact of air pollution on asthma exacerbation. Further, they refer to studies from New York City examining the air pollution in various boroughs. It would be very interesting to use these data to challenge the findings in the present study. Is there any possibility to to so? 
REVIEWER

GENERAL COMMENTS
This study examined the correlation between asthma and influenza hospitalizations population-level patterns. This study seemed to be interesting, however, the following points should be discussed.
Major comment I am not sure that the data really demonstrate the close correlation between influenza hospitalization and asthma attack throughout the year especially in adults.
Is it true?
Minor comment How was the seasonal predilection of viral infection among asthma hospitalized patients in United States? Authors should describe the facts by citing the previous reports.
REVIEWER
Hideto TAKAHASHI National Institute of Public Health,JAPAN REVIEW RETURNED 10-Jan-2018
GENERAL COMMENTS
Major Comments:
(1)The authors considered the correlation of asthma and influenza hospitalizations. But the relationship between asthma and influenza is already well-known. In this situation that both hospitalities are also expected to correlate, it is not clear either academic or political value to reveal the relationship of asthma and influenza hospitalizations.
(2)This study was ecological study. So the statistical relationship itself might be ecologic fallacy. The examination of causality between asthma and influenza would not be sufficient enough to consider aggregate monthly counts of influenza hospitalizations as predictors of asthma hospitalizations. The authors should consider by not only statistical sense but also pathogenic one. 
The authors of this manuscript investigated the temporal and spatial associations between influenza and asthma hospitalization in New York. My major concern with this manuscript is in the statistical methodology adopted to study the bivariate association and other risk factors.
Firstly, incidence of asthma may not be directly link to a single day incidence of influenza disease. The relationship may play out over few days in the future. Distributed lag models will answer this type of question. What is the time lag operator used in the time series models discussed in the paper?
The following paper provides an excellent read on bivariate analysis of counts data: Paul, M., Held, L., & Toschke, A. M. (2008) . Multivariate modelling of infectious disease surveillance data. Statistics in medicine, 27(29), 6250-6267.
Additionally, the statistical analyses and thus the results thereafter, would be straight forward and easily understood if some of model specifications were provided. I will suggest that equations for the models should be explicitly written to give an idea of the variables included in the model and to shed light on the model specification.
Secondly, it will be nice to visualize the spatial distribution of the two diseases on the map of New York.
REVIEWER
Natalie Dean
University of Florida, USA REVIEW RETURNED 01-Mar-2018
GENERAL COMMENTS
This paper on influenza and asthma provides a nice analysis of hospitalization data in NYC. The paper is well-structured and wellwritten. I have only a few suggestions for improvements.
1. I don't think the broad conclusion in the abstract and discussion is supported by the results -"The results from time series analysis indicate that flu and asthma hospitalizations are significantly correlated." Your results indicate that this correlation only exists for adults, as no significant correlation is observed for children. Any overall test of significance is driven by the adults and isn't meaningful because of the heterogeneity across ages. (This correlation was also only observed in two of five boroughs.) The primary conclusion should be tempered. Similarly, the last sentence of this paragraph should be rephrased. "…may lead to reduction of asthma hospitalizations in adults." I would suggest leading with this more interesting difference between the adult and pediatric populations in the first paragraph instead of generic statements about temporal and spatial correlation.
2. This study seems to lack an important covariate -pollen. Looking at Supplementary Figure 1 (which I personally prefer over Figure 1 in the main text), there is a big peak in asthma hospitalizations in the spring and then a rise in the fall that I am sure corresponds with allergies. I am not sure how much pollen levels vary year to year and so might be captured by seasonality, but certainly the timing could vary depending on weather. Data on pollen levels must be publicly available. Why was this covariate not incorporated into the model? 3. The method described for the calculation of excess risk strikes me as a bit unusual. What if there were several months of high influenza in a season? This would raise the 11-month "unexposed" average. Similarly, the use of a calendar year (Jan to Dec) is tough because influenza season is October through May. What if there was a particularly bad season such that the peak month is December for one year and January for the next year (so only truly reflects a single flu season). Also, what if a particular year is low for the flu? What does it then mean to hypothetically decrease flu hospitalizations during the peak month? Unfortunately I have more criticisms than suggested solutions, but I hope this can be examined a bit further.
Minor: -Page 4, line 20: "lost of productivity" -> "loss of productivity" -Page 4, line 51: "hospitalizations rates" -> "hospitalization rates" -Page 5, line 27: "less so among children due to differences in asthma seasonality." This could use another few words of explanation. What does asthma seasonality look like in children? It is not described earlier in the introduction. I know it is described in the results, but it could use more explanation of why you expected this in advance.
-Page 10, Line 7: "monthly averag
VERSION 1 -AUTHOR RESPONSE
Reviewers' comments are shown below in italics, followed by our responses in plain text.
REVIEWER 1:
Reviewer Thank you for the idea to include this information, which we agree provides helpful context. We have added the following to our manuscript Introduction and Limitations:
"In the 2012-2013 influenza season, pediatric influenza vaccination prevalences in New York City were 65% for 6-59 month olds, 47% for 5-8 year olds, and 31% for 9-17 year olds 15 . These prevalences were below the national goal of 80% and below the 2012-2013 national influenza vaccination coverage of 76.9% for 6-23 month olds, 65.8% for 2-4 year olds, 58.6% for 5-12 year olds, and 42.5% for 13-17 year olds 15 . Nationally, vaccine coverage has generally risen each year amongst children (6 months to 17 years) and adults (18) "Finally, our work relied on diagnostic codes available in the hospitalization data provided to New York state. There could be variability in the diagnostic criteria of influenza and asthma by clinician, institution, and time that would alter the pattern observed in our study."
Co-infection are not taken into account in the analysis. Is this information available and could be fitted in the model?
Thanks for this suggestion, which could be an important future research direction, but is beyond the scope of the present investigation.
Before 2006, RV-C infections could not be diagnosed. This may have affected studies on seasonality correlation between asthma and rhinovirus infection. The references provided in this
article on the subject (5, 8, 9) are up-to-date.
Thank you for raising the possibility that diagnostic changes may have affected the patterns seen across our study period. We have made an additional change to our limitations paragraph to reflect issues with influenza diagnostic changes.
Conclusion should be rephrased from `influenza hospitalizations are significantly correlated with asthma hospitalizations at the population-level` to `influenza hospitalizations are significantly correlated with asthma hospitalizations at the population-level among adults (>18 years old)`.
We have made this suggested change to the wording of our conclusion, which we agree more specifically reflects our findings. Thank you for this suggestion. We were asked to describe all statistical methods, including those used to examine subgroups and interactions. We wanted to provide adequate description of our methods to satisfy the level of detail required in the STROBE checklist, but are happy to move text to the supplement at the request of the editor.
REVIEWER: 4
The authors have used SPARCS to extract data. Although SPARCS is briefly explained it is necessary with a reference.
We have added a reference at the beginning of the methods section.
Page 7, line 16: AIC needs a brief explanation and/or a reference.
We have added a reference so that the interested reader can learn more if unfamiliar with AIC.
The authors calculate the percent excess risk to identify a peak month. Was is the rationale for using 1 months and not e.g. 2 months or 8 weeks?
While the choice of 1 month is admittedly somewhat arbitrary there was no standard clinically driven reason to consider other time periods so we aggregated by months to be consistent with the monthly aggregations used in our ARIMA modeling. Additionally, we believe it serves the role of helping to provide the reader with guidance in understanding the magnitude of the observed association by using a time scale that is not too broad nor too specific.
Results: 4.7. The authors explain the peak in influenza cases in 2009 with a good explanation (Figure 1). The same plot reveals two other peaks in asthma exacerbations in 2004 and 2005, but the authors do not mention these? Why are these not interesting?
We do find each of the peaks of interest, and readers will be able to see them in the provided figures. However, the 2009 peak is given particular attention because of occurring "off season" in June.
Discussion
The authors define age groups and find that the correlation between influenza and astma was only significant amongst age groups 18 and older. Do the authors have any reason to believe that the correlation is present/absent with 18 years of age as a cut-off? A sensitivity analysis would be preferable.
As discussed, age was one of the potential effect measure modifiers considered, and the patterns were shown graphically in Figure 2 . The 5-18 year old age group was conceived of as school-age, and we considered that the school year could play a role for this age in the timing of medical attention for asthma. Indeed, our supplemental materials (Supplemental Figure 2) show a fall increase in asthma hospitalizations for children that is not evident for adults. In the Discussion section we have added some more information on the differences in seasonal peaks observed between children and adults and what may be accounting for those asthma hospitalization peaks.
Page 11, line 58, needs some references.
We have added references.
The authors (very relevantly) discuss the impact of air pollution on asthma exacerbation. Further, they refer to studies from New York City examining the air pollution in various boroughs. It would be very interesting to use these data to challenge the findings in the present study. Is there any possibility to to so?
This is an important direction for future exploration, but is beyond the scope of the present investigation. Thank you for your interest in our work, and the suggestions for improvement.
REVIEWER: 5
Major comment 5.2. I am not sure that the data really demonstrate the close correlation between influenza hospitalization and asthma attack throughout the year especially in adults. Is it true?
The reviewer appears to be asking about whether effect modification by age (specifically for adults versus children) is really evident. While this is our interpretation, we endeavor to provide readers with enough context to judge this for themselves and would welcome future work that challenges or reinforces this conclusion.
Minor comment 5.3. How was the seasonal predilection of viral infection among asthma hospitalized patients in United States? Authors should describe the facts by citing the previous reports.
Thanks for raising this point. While the seasonal pattern is mentioned in brief in our introduction, we agree that citing previous reports is appropriate and helpful to readers. We have added references accordingly. While we agree that the idea of asthma and influenza being related is not entirely novel, we hope that our efforts to quantify and qualify this relationship spatially and temporally at the population-level are of interest to those interested in reducing the burden of asthma, particularly in creating more targeted influenza vaccine campaigns.
REVIEWER: 6
This study was ecological study. So the statistical relationship itself might be ecologic fallacy. The examination of causality between asthma and influenza would not be sufficient enough to consider aggregate monthly counts of influenza hospitalizations as predictors of asthma hospitalizations. The authors should consider by not only statistical sense but also pathogenic one.
We agree that caution is appropriate when working with ecological data, and we have noted in our limitations that "the findings of this hypothesis-generating study cannot necessarily be used to draw causal inferences at the individual level."
The study area was Manhattan, Bronx, Queens, Brooklyn and Staten Island, which was limited area. I am afraid whether the model and the results hold widely or not.
We appreciate and share this reviewer's concerns about generalizability beyond New York City, and have added to our limitations section an acknowledgement of this.
In addition, concerning to the model building, it is not clear how the authors reached the most appropriate model of the AR(1) with a term of the seasonality. Are there other possibilities of the model, AR(2) or AR(1) with other explanatory variables?
Our modeling approach was informed by our goals of fitting the data well and providing an interpretable graphical and numeric answer to our research question. The order of AR or MA terms in the ARIMA model were identified based on the partial autocorrelation (PACF) and autocorrelation function (ACF) of the seasonally differenced series. In our PACF assessment there was a significant spike at lag 1 with no other significant lags until lag 12. This accompanied with the ACF plot where we see a tapering pattern in the early lags of the ACF caused us to consider a nonseasonal AR(1) in our model.
In determining our final model we examined AIC to assess goodness of fit between different models that were tried and examined the ACF and PACF residuals to ensure that no pattern was left and that there was no presence of significant white noise probabilities. We have added these details to the manuscript under the Methods section on fitting the Seasonal ARIMA Model and added additional figures and information into our Supplemental materials.
REVIEWER: 7
Reviewer Name: Oyelola Adegboye The following paper provides an excellent read on bivariate analysis of counts data: Paul, M., Held, L., & Toschke, A. M. (2008) . Multivariate modelling of infectious disease surveillance data. Statistics in medicine, 27(29), [6250] [6251] [6252] [6253] [6254] [6255] [6256] [6257] [6258] [6259] [6260] [6261] [6262] [6263] [6264] [6265] [6266] [6267] Thank you for raising this concern.
The final seasonal ARIMA (1,1,0)x(0,1,1) 12 accommodates lags at 1, 2, 12, 13, and 14 in the AR model and lag at 12 in the MA model. Our final model includes (1) Therefore, we can see that the AR model has lags at 1, 2, 12, 13 and 14. In addition, the MA model has a lag at 12. We have added a model statement in the methods section in the hope of making our methods transparent and easily understood.
The final SARIMA (1,1,0)x(0,1,1) 12 is written as below: Thank you for suggesting this clarification to our conclusions. We have now updated the wording in our abstract and, as noted above in our response to comment 3.4, we have changed the wording in our discussion to more clearly delimit our conclusion. Supplementary Figure 1 (which I personally prefer over Figure 1 in Thank you for raising this important issue. Spring pollen peaks are indeed associated with asthma exacerbations. We performed a sensitivity analysis excluding the spring pollen season from each year (March-May) and found that it did not change our results and strengthened our ARIMA estimate for flu predicting asthma (0.0660.02, p=0.0018). We have additionally made changes to our manuscript in the Discussion section that discuss the influence of pollen and noted our sensitivity analysis in our Methods and Results section. Thank you for prompting us to think carefully about this. We provide the calculation of excess risk to help readers understand the magnitude of the observed associations, but we agree that the approach is imperfect. : 8.5 . Page 4, line 20: "lost of productivity" -> "loss of productivity"
This study seems to lack an important covariate -pollen. Looking at
Minor
